Catalyst Ends Free Genetic Testing in Alabama
Southern Research's program reached more than 9,300 Alabama participants before enrollment closed on September 30.
Updated on Nov. 2, 2026 in Life Sciences
Live Poll
Should state and local governments fund free genetic testing programs for residents?
Southern Research's Catalyst program provided free clinical genetic testing to more than 9,300 Alabama participants, returning more than 5,600 results. Enrollment closed September 30 as the organization's current grant period ended.
Why it matters
The program offered Alabama residents access to inherited-risk and medication-response information at no cost, funded by state and Birmingham city grants. Its closure leaves enrollment dependent on whether additional funding becomes available.
The figures come from Catalyst's own program counts of enrolled participants and returned results, covering 9,300 people and 5,600 results across 67 counties. It is not stated whether all enrolled participants will have their results returned, and the status of any future funding remains unannounced.
The players
Southern Research
Southern Research is a nonprofit scientific research organization based in Birmingham that operates the Catalyst genetic testing program.
Catalyst
Catalyst is the free clinical genetic testing program run by Southern Research that served residents across Alabama.
The details
Participants received a home kit, collected a cheek swab and mailed it back for analysis. The testing examined selected inherited risks for heart disease, type 2 diabetes and certain cancers, and information on how genes may affect response to more than 70 common medications. Catalyst attended more than 400 community events during the program.
Timeline
October 2024: Catalyst program launched offering free genetic testing.
September 30: Enrollment closed as the current grant period ended.
Within 90 days of order date: Enrolled participants who have not returned samples may still do so.
Big Picture
Catalyst's model of mailing home swab kits and returning pharmacogenetic results is a direct, state-funded example of population-level genetic screening outside a clinical setting. Its enrollment closed when grant funding ran out, showing how such programs depend on renewable public grants.
Alabama residents who did not enroll before September 30 no longer have access to this no-cost testing through the program. Those already enrolled who have not yet returned their swabs have 90 days from their order date to do so.
The takeaway
Residents who want genetic insight into medication response or inherited health risks should check whether their clinician offers similar testing, since this free program is no longer enrolling. Those enrolled should return any outstanding swab within the 90-day window.
What happens next
Enrollment could reopen if additional funding becomes available, though no date has been set.
Further reading
Explore more Life Sciences coverage across Alabama.
Source note: This article includes information reported by Yellowhammer News.
Live Poll
Should state and local governments fund free genetic testing programs for residents?
